• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

After going ‘crazy’ over the science, Merck signs up a new partner in the hunt for an HIV cure

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jul 13, 2020 at 11:22: AM
via Less than a year after inking a $100 million licensing deal with German giant Bayer, Dewpoint Therapeutics has scored another big-time contract, this time with Merck. And this collaboration came together in a particularly unusual fashion.

article source
 




Top Bottom
Back
Quote